DENALI THERAPEUTICS INC

Ticker: DNLI CUSIP: 24823R105 Class: Common Stock

Connor, Clark & Lunn Investment Management Ltd.'s Holding History (CIK: 0001596800)

Note: Option positions (PUT/CALL) are excluded.

Q4 2022

Shares 61,096 Value ($000) $1,699 Avg Close $29.75 Range $25.96 - $34.78

Q3 2022

Shares 112,532 Value ($000) $3,454 Avg Close $32.51 Range $25.88 - $39.43

Q2 2021

Shares 19,993 Value ($000) $1,568 Avg Close $61.86 Range $49.20 - $79.70

Q1 2021

Shares 37,906 Value ($000) $2,164 Avg Close $66.94 Range $52.23 - $84.25

Q4 2020

Shares 19,677 Value ($000) $1,648 Avg Close $60.45 Range $35.89 - $93.94

Period	Shares	Value ($000)	Average Close	Price Range
Q4 2022	61,096	$1,699	$29.75	$25.96 - $34.78
Q3 2022	112,532	$3,454	$32.51	$25.88 - $39.43
Q2 2021	19,993	$1,568	$61.86	$49.20 - $79.70
Q1 2021	37,906	$2,164	$66.94	$52.23 - $84.25
Q4 2020	19,677	$1,648	$60.45	$35.89 - $93.94